Health

Pfizer begins human testing of new Covid-19 pill

Pfizer Inc. announced that it has begun human safety testing of a new pill to treat the coronavirus, which could be used at the first sign of illness.

If it succeeds in trials, the pill could be prescribed early in an infection to block viral replication. The drug binds to an enzyme called a protease to keep the virus from replicating. Protease-inhibiting medicines have been successful in treating other types of viruses, include HIV and Hepatitis C.

The new protease inhibitor is the second such medicine Pfizer has brought into human trials to treat Covid-19. Pfizer is testing another given intravenously to hospitalized virus patients.

Pfizer said it plans to share more data on the compound at the American Chemical Society meeting on April 6.

Comments

Source
bhnews

Related Articles

Back to top button